首页> 外文OA文献 >The development and validation of HPLC-DMD method for intermediate products impurities determination of morpholinium 2-((4-(2-methoxyphenyl)-5-(pyridine-4-yl)-4H-1,2,4-triazole-3-yl)thio)acetate in bulk drug

【2h】

The development and validation of HPLC-DMD method for intermediate products impurities determination of morpholinium 2-((4-(2-methoxyphenyl)-5-(pyridine-4-yl)-4H-1,2,4-triazole-3-yl)thio)acetate in bulk drug

机译：HPLC-DMD方法对中间产物杂质的含量测定吗啉代酮2 - （（4-（2-甲氧基苯基）-5-（吡啶-4-基）-4H-1,2,4-三唑-3- YL）Thio）植物散装药物

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
B. O. Varynskyi; A. G. Kaplaushenko;
展开▼
作者单位

展开▼
年度 2017
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Metabolism study of morpholinium 2- ((4- (2-methoxyphenyl)-5-(pyridin-4-yl) -4H-1,2,4-triazole-3-yl)thio) acetate [J] . Borys Varynskyi, Andriy Kaplaushenko Current Issues in Pharmacy and Medical Sciences . 2020,第2期

机译：吗啉代谢的2-（（4-（2-甲氧基苯基）-5-（吡啶-4-基）-4H-1,2,4-三唑-3-基-3-基）硫乙酯
2. The development of HPLC-DAD method for determination of active pharmaceutical ingredient in the potassium 2-((4-amino-5-(morpholinomethyl)-4H-1,2,4-triazol-3-yl)thio) acetate substance [J] . Roman Shcherbyna, Volodymyr Parchenko, Boris Varynskyi, Current Issues in Pharmacy and Medical Sciences . 2019,第1期

机译：HPLC-DAD法测定2-（（4-氨基-5-（吗啉代甲基）-4H-1,2,4-三唑-3-基）硫代）乙酸钾物质中活性药物成分的方法开发
3. Development and validation of stability-indicating RP-HPLC method for determination of Olmesartan medoxomile in pharmaceutical dosage form and identification, characterization of alkaline degradation impurity of Olmesartan medoxomile drug substance as well as drug product [J] . Jain P.S., Chaudhari A.J., Surana S.J. Chemical Industry Chemical Engineering Quarterly . 2012,第4a1期

机译：稳定剂型RP-HPLC法测定奥美沙坦片中奥美沙坦的质量，鉴定和表征奥美沙坦片中的碱性降解杂质及药物的开发与验证
4. Method development and validation for determination of thiocolchicoside in drug product using reversed liquid chromatogrpahy. [D] . Pacek Parad, Monika. 2016

机译：使用反向液相色谱法测定药品中的硫代秋水仙苷的方法开发和验证。
5. RP-HPLC Method Development and Validation for Determination of Eptifibatide Acetate in Bulk Drug Substance and Pharmaceutical Dosage Forms [O] . Maryam Bavand Savadkouhi, Hossein Vahidi, Abdul Majid Ayatollahi, 2017

机译：RP-HPLC方法开发和定量测定大批量药物形式和药物剂型中的依替巴肽
6. Metabolism study of morpholinium 2- ((4- (2-methoxyphenyl)-5-(pyridin-4-yl) -4H-1,2,4-triazole-3-yl)thio) acetate [O] . Borys Varynskyi, Andriy Kaplaushenko 2020

机译：吗啉代谢的2-（（4-（2-甲氧基苯基）-5-（吡啶-4-基）-4H-1,2,4-三唑-3-基-3-基）硫乙酯

The development and validation of HPLC-DMD method for intermediate products impurities determination of morpholinium 2-((4-(2-methoxyphenyl)-5-(pyridine-4-yl)-4H-1,2,4-triazole-3-yl)thio)acetate in bulk drug

著录项

引文网络

相似文献

相关主题

期刊订阅